Literature DB >> 25348318

Functional analysis of HPV-like particle-activated Langerhans cells in vitro.

Lisa Yan1, Andrew W Woodham, Diane M Da Silva, W Martin Kast.   

Abstract

Langerhans cells (LCs) are antigen-presenting cells responsible for initiating an immune response against human papillomaviruses (HPVs) entering the epithelial layer in vivo as they are the first immune cell that HPV comes into contact with. LCs become activated in response to foreign antigens, which causes internal signaling resulting in the increased expression of co-stimulatory molecules and the secretion of inflammatory cytokines. Functionally activated LCs are then capable of migrating to the lymph nodes where they interact with antigen-specific T cells and initiate an adaptive T-cell response in vivo. However, HPV has evolved in a manner that suppresses LC function, and thus the induction of antigen-specific T cells is hindered. While many methods exist to monitor the activity of LCs in vitro, the migration and induction of cytotoxic T cells is ultimately indicative of a functional immune response. Here, methods in analyzing functional migration and induction of antigen-specific T cells after stimulation of LCs with HPV virus-like particles in vitro are described.

Entities:  

Mesh:

Year:  2015        PMID: 25348318      PMCID: PMC4955845          DOI: 10.1007/978-1-4939-2013-6_25

Source DB:  PubMed          Journal:  Methods Mol Biol        ISSN: 1064-3745


  16 in total

1.  Human papillomavirus is a necessary cause of invasive cervical cancer worldwide.

Authors:  J M Walboomers; M V Jacobs; M M Manos; F X Bosch; J A Kummer; K V Shah; P J Snijders; J Peto; C J Meijer; N Muñoz
Journal:  J Pathol       Date:  1999-09       Impact factor: 7.996

2.  Dendritic cells acquire antigen from apoptotic cells and induce class I-restricted CTLs.

Authors:  M L Albert; B Sauter; N Bhardwaj
Journal:  Nature       Date:  1998-03-05       Impact factor: 49.962

3.  Differential uptake and cross-presentation of human papillomavirus virus-like particles by dendritic cells and Langerhans cells.

Authors:  Steven C Fausch; Diane M Da Silva; W Martin Kast
Journal:  Cancer Res       Date:  2003-07-01       Impact factor: 12.701

4.  Papillomavirus L1 major capsid protein self-assembles into virus-like particles that are highly immunogenic.

Authors:  R Kirnbauer; F Booy; N Cheng; D R Lowy; J T Schiller
Journal:  Proc Natl Acad Sci U S A       Date:  1992-12-15       Impact factor: 11.205

5.  Despite differences between dendritic cells and Langerhans cells in the mechanism of papillomavirus-like particle antigen uptake, both cells cross-prime T cells.

Authors:  Mengyong Yan; Judy Peng; Ibtissam A Jabbar; Xiaosong Liu; Luis Filgueira; Ian H Frazer; Ranjeny Thomas
Journal:  Virology       Date:  2004-07-01       Impact factor: 3.616

Review 6.  HPV: from infection to cancer.

Authors:  M A Stanley; M R Pett; N Coleman
Journal:  Biochem Soc Trans       Date:  2007-12       Impact factor: 5.407

7.  Prevalence of human papillomavirus in cervical cancer: a worldwide perspective. International biological study on cervical cancer (IBSCC) Study Group.

Authors:  F X Bosch; M M Manos; N Muñoz; M Sherman; A M Jansen; J Peto; M H Schiffman; V Moreno; R Kurman; K V Shah
Journal:  J Natl Cancer Inst       Date:  1995-06-07       Impact factor: 13.506

Review 8.  Origin, homeostasis and function of Langerhans cells and other langerin-expressing dendritic cells.

Authors:  Miriam Merad; Florent Ginhoux; Matthew Collin
Journal:  Nat Rev Immunol       Date:  2008-12       Impact factor: 53.106

9.  Human Langerhans cells selectively activated via Toll-like receptor 2 agonists acquire migratory and CD4+T cell stimulatory capacity.

Authors:  Matthias Peiser; Juliana Koeck; Carsten J Kirschning; Burghardt Wittig; Reinhard Wanner
Journal:  J Leukoc Biol       Date:  2008-02-05       Impact factor: 4.962

Review 10.  Human papillomavirus type 16 late gene expression is regulated by cellular RNA processing factors in response to epithelial differentiation.

Authors:  Sarah A Cumming; Thanaporn Cheun-Im; Stephen G Milligan; Sheila V Graham
Journal:  Biochem Soc Trans       Date:  2008-06       Impact factor: 5.407

View more
  10 in total

1.  Nanobody-Antigen Conjugates Elicit HPV-Specific Antitumor Immune Responses.

Authors:  Andrew W Woodham; Ross W Cheloha; Jingjing Ling; Mohammad Rashidian; Stephen C Kolifrath; Maia Mesyngier; Joao N Duarte; Justin M Bader; Joseph G Skeate; Diane M Da Silva; W Martin Kast; Hidde L Ploegh
Journal:  Cancer Immunol Res       Date:  2018-05-23       Impact factor: 11.151

2.  Recognition of Class II MHC Peptide Ligands That Contain β-Amino Acids.

Authors:  Ross W Cheloha; Andrew W Woodham; Djenet Bousbaine; Tong Wang; Shi Liu; John Sidney; Alessandro Sette; Samuel H Gellman; Hidde L Ploegh
Journal:  J Immunol       Date:  2019-08-07       Impact factor: 5.422

3.  Langerhans cells from women with cervical precancerous lesions become functionally responsive against human papillomavirus after activation with stabilized Poly-I:C.

Authors:  Diane M Da Silva; Andrew W Woodham; Joseph G Skeate; Laurie K Rijkee; Julia R Taylor; Heike E Brand; Laila I Muderspach; Lynda D Roman; Annie A Yessaian; Huyen Q Pham; Koji Matsuo; Yvonne G Lin; Greg M McKee; Andres M Salazar; W Martin Kast
Journal:  Clin Immunol       Date:  2015-09-08       Impact factor: 3.969

4.  In vivo detection of antigen-specific CD8+ T cells by immuno-positron emission tomography.

Authors:  Andrew W Woodham; Stad H Zeigler; Ella L Zeyang; Stephen C Kolifrath; Ross W Cheloha; Mohammad Rashidian; Rodolfo J Chaparro; Ronald D Seidel; Scott J Garforth; Jason L Dearling; Maia Mesyngier; Phaneendra K Duddempudi; Alan B Packard; Steven C Almo; Hidde L Ploegh
Journal:  Nat Methods       Date:  2020-09-14       Impact factor: 28.547

5.  Human papillomavirus-exposed Langerhans cells are activated by stabilized Poly-I:C.

Authors:  Diane M Da Silva; Andrew W Woodham; Laurie K Rijkee; Joseph G Skeate; Julia R Taylor; Maaike E Koopman; Heike E Brand; Michael K Wong; Greg M McKee; Andres M Salazar; W Martin Kast
Journal:  Papillomavirus Res       Date:  2015-12-01

6.  Immunostimulatory Activity of the Cytokine-Based Biologic, IRX-2, on Human Papillomavirus-Exposed Langerhans Cells.

Authors:  Diane M Da Silva; Andrew W Woodham; Paul H Naylor; James E Egan; Neil L Berinstein; W Martin Kast
Journal:  J Interferon Cytokine Res       Date:  2015-12-10       Impact factor: 2.607

7.  T cell ignorance is bliss: T cells are not tolerized by Langerhans cells presenting human papillomavirus antigens in the absence of costimulation.

Authors:  Andrew W Woodham; Lisa Yan; Joseph G Skeate; Daniel van der Veen; Heike H Brand; Michael K Wong; Diane M Da Silva; W Martin Kast
Journal:  Papillomavirus Res       Date:  2016-12

8.  Efficacy of intracellular immune checkpoint-silenced DC vaccine.

Authors:  Danhong Wang; Xue F Huang; Bangxing Hong; Xiao-Tong Song; Liangding Hu; Min Jiang; Bin Zhang; Hongmei Ning; Yuhang Li; Chen Xu; Xiao Lou; Botao Li; Zhiyong Yu; Jiangwei Hu; Jianlin Chen; Fan Yang; Haiyan Gao; Guoliang Ding; Lianming Liao; Lisa Rollins; Lindsey Jones; Si-Yi Chen; Hu Chen
Journal:  JCI Insight       Date:  2018-02-08

9.  Interactions of Human Dermal Dendritic Cells and Langerhans Cells Treated with Hyalomma Tick Saliva with Crimean-Congo Hemorrhagic Fever Virus.

Authors:  Sergio E Rodriguez; Alexander J McAuley; Aysen Gargili; Dennis A Bente
Journal:  Viruses       Date:  2018-07-20       Impact factor: 5.048

10.  Expressionof langerhans cell and plasmacytoid dendritic cell markers, and toll-like receptor 7/9 signaling pathway proteins in verruca vulgaris lesions.

Authors:  Yi Tang; Xiaoxia Zhu; Rui Han; Qiang Zhou; Hao Cheng
Journal:  Medicine (Baltimore)       Date:  2020-02       Impact factor: 1.817

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.